A Unique Prototypic Device for Radiation Therapy: The p53-Independent Antiproliferative Effect of Neutron Radiation

• Published in: Actanaturae Vol. 11; no. 3; pp. 99 - 102
• Main Authors: Yurkov, D. I., Syromukov, S. V., Tatarskiy, V. V., Ivanova, E. S., Khamidullina, A. I., Yastrebova, M. A., Sysoev, V. I., Dobrov, R. V., Belousov, A. V., Morozov, V. N., Kolyvanova, M. A., Krusanov, G. A., Zverev, V. I., Shtil, A. A.
• Format: Journal Article
• Language: English
• Published: A.I. Gordeyev 01.07.2019
• ISSN: 2075-8251
• DOI: 10.32607/20758251-2019-11-3-99-102

Radiation therapy with heavy particles including neutrons, an otherwise therapeutically perspective because of its high tissue penetration and efficient tumor damage, is currently limited by the lack of adequate equipment. An NG-24 generator (140 kg, 42 110 cm, ~1011 particles/s, 14 MeV) has been designed and engineered to replace the huge and environmentally harmful neutron reactors, cyclotrons, and accelerators with a compact, portable, safe, and potent source of high-energy neutrons. We demonstrate that the neutron beam produced by NG-24 causes a significant antiproliferative effect on human tumor cell lines regardless of the status of the anti-apoptotic p53 protein. Phosphorylation of histone 2A and increased amounts of p21, cyclin D, and phospho-p53 were detectable in HCT116 colon carcinoma cells (wild-type p53) irradiated with 4 Gy several days post-treatment, accompanied by G2/M phase arrest. These treatments dramatically reduced the ability of single cells to form colonies. In the HCT116p53KO subline (p53 -/-), the G2/M arrest was independent of the aforementioned mechanisms. Hence, the NG-24 generator is a source of a powerful, therapeutically relevant neutron flux that triggers a p53-independent antiproliferative response in tumor cells.